H3 K27M

Clinical trials for H3 K27M explained in plain language.

Never miss a new study

Get alerted when new H3 K27M trials appear

Sign up with your email to follow new studies for H3 K27M, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Promising new drug targets rare childhood brain cancer in global trial

Disease control Recruiting now

This study tests whether the drug ONC201 can help people with a rare and aggressive brain tumor called H3 K27M-mutant glioma live longer. Participants must have completed standard radiation therapy. The trial is double-blind, meaning neither patients nor doctors know who gets the…

Matched conditions: H3 K27M

Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

H3 K27M

Get alerted when new H3 K27M trials appear

Promising new drug targets rare childhood brain cancer in global trial